These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17210251)

  • 1. Synthesis and evaluation of aryl thioxothiazolidinone inhibitors of ADAMTS-5 (Aggrecanase-2).
    Bursavich MG; Gilbert AM; Lombardi S; Georgiadis KE; Reifenberg E; Flannery CR; Morris EA
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1185-8. PubMed ID: 17210251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5.
    Gilbert AM; Bursavich MG; Lombardi S; Georgiadis KE; Reifenberg E; Flannery CR; Morris EA
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1189-92. PubMed ID: 17210252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors.
    Atobe M; Maekawara N; Ishiguro N; Sogame S; Suenaga Y; Kawanishi M; Suzuki H; Jinno N; Tanaka E; Miyoshi S
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2106-10. PubMed ID: 23453070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.
    Sogame S; Suenaga Y; Atobe M; Kawanishi M; Tanaka E; Miyoshi S
    Eur J Med Chem; 2014 Jan; 71():250-8. PubMed ID: 24316668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitors.
    Shiozaki M; Maeda K; Miura T; Ogoshi Y; Haas J; Fryer AM; Laird ER; Littmann NM; Andrews SW; Josey JA; Mimura T; Shinozaki Y; Yoshiuchi H; Inaba T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1575-80. PubMed ID: 19243944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2).
    Gilbert AM; Bursavich MG; Lombardi S; Georgiadis KE; Reifenberg E; Flannery CR; Morris EA
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6454-7. PubMed ID: 18974001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potent and selective hydantoin inhibitors of aggrecanase-1 and aggrecanase-2 that are efficacious in both chemical and surgical models of osteoarthritis.
    Durham TB; Klimkowski VJ; Rito CJ; Marimuthu J; Toth JL; Liu C; Durbin JD; Stout SL; Adams L; Swearingen C; Lin C; Chambers MG; Thirunavukkarasu K; Wiley MR
    J Med Chem; 2014 Dec; 57(24):10476-85. PubMed ID: 25415648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.
    Maingot L; Elbakali J; Dumont J; Bosc D; Cousaert N; Urban A; Deglane G; Villoutreix B; Nagase H; Sperandio O; Leroux F; Deprez B; Deprez-Poulain R
    Eur J Med Chem; 2013 Nov; 69():244-61. PubMed ID: 24044937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and SAR investigation of thienosultam derivatives as ADAMTS-5 (aggrecanase-2) inhibitors.
    Atobe M; Maekawara N; Kawanishi M; Suzuki H; Tanaka E; Miyoshi S
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2111-6. PubMed ID: 23453072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).
    Deng H; O'Keefe H; Davie CP; Lind KE; Acharya RA; Franklin GJ; Larkin J; Matico R; Neeb M; Thompson MM; Lohr T; Gross JW; Centrella PA; O'Donovan GK; Bedard KL; van Vloten K; Mataruse S; Skinner SR; Belyanskaya SL; Carpenter TY; Shearer TW; Clark MA; Cuozzo JW; Arico-Muendel CC; Morgan BA
    J Med Chem; 2012 Aug; 55(16):7061-79. PubMed ID: 22891645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2).
    Bursavich MG; Gilbert AM; Lombardi S; Georgiadis KE; Reifenberg E; Flannery CR; Morris EA
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5630-3. PubMed ID: 17804234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors.
    Shiozaki M; Imai H; Maeda K; Miura T; Yasue K; Suma A; Yokota M; Ogoshi Y; Haas J; Fryer AM; Laird ER; Littmann NM; Andrews SW; Josey JA; Mimura T; Shinozaki Y; Yoshiuchi H; Inaba T
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6213-7. PubMed ID: 19767207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New non-hydroxamic ADAMTS-5 inhibitors based on the 1,2,4-triazole-3-thiol scaffold.
    Maingot L; Leroux F; Landry V; Dumont J; Nagase H; Villoutreix B; Sperandio O; Deprez-Poulain R; Deprez B
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6213-6. PubMed ID: 20846863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.
    De Savi C; Pape A; Sawyer Y; Milne D; Davies C; Cumming JG; Ting A; Lamont S; Smith PD; Tart J; Page K; Moore P
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3301-6. PubMed ID: 21536437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis.
    Apte SS
    Biochem J; 2016 Jan; 473(1):e1-4. PubMed ID: 26657033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
    Nuti E; Santamaria S; Casalini F; Yamamoto K; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Marini AM; Salerno S; Taliani S; Da Settimo F; Nagase H; Rossello A
    Eur J Med Chem; 2013 Apr; 62():379-94. PubMed ID: 23376997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose.
    Durham TB; Marimuthu J; Toth JL; Liu C; Adams L; Mudra DR; Swearingen C; Lin C; Chambers MG; Thirunavukkarasu K; Wiley MR
    J Med Chem; 2017 Jul; 60(13):5933-5939. PubMed ID: 28613895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2).
    Shieh HS; Mathis KJ; Williams JM; Hills RL; Wiese JF; Benson TE; Kiefer JR; Marino MH; Carroll JN; Leone JW; Malfait AM; Arner EC; Tortorella MD; Tomasselli A
    J Biol Chem; 2008 Jan; 283(3):1501-1507. PubMed ID: 17991750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.
    Govinda Rao B; Bandarage UK; Wang T; Come JH; Perola E; Wei Y; Tian SK; Saunders JO
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2250-3. PubMed ID: 17289381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity study on a series of α-glutamic acid scaffold based compounds as new ADAMTS inhibitors.
    Peng L; Duan L; Liu X; Shen M; Li Y; Yan J; Li H; Ding K
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4457-61. PubMed ID: 21733683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.